EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Understanding the Role of Adipokines in Cardiometabolic Dysfunction: A Review of Current Knowledge

Sayantap Datta, Saisudha Koka, Krishna M Boini iD

Biomolecules · 23.04.2025 · 15 (5) · 612

DOI: 10.3390/biom15050612 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Biomolecules, online erschienen am 23.04.2025. Verfasst von Sayantap Datta und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacological and Pharmaceutical Sciences, College of Pharmacy, University of Houston, 4349 Martin Luther King Blvd., Houston, TX 772…. Hauptthemen laut MEDLINE: Adipokines, Cardiovascular Diseases. Die Arbeit wurde bisher 34-mal zitiert (Crossref) und nennt 440 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NHLBI NIH HHS, NIH HHS, National Institute of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cardiometabolic risk and associated dysfunctions contribute largely to the recent rise in mortality globally. Advancements in multi-omics in recent years promise a better understanding of potential biomarkers that enable an early diagnosis of cardiometabolic dysfunction. However, the molecular mechanisms driving the onset and progression of cardiometabolic disorders remain poorly understood. Adipokines are adipocyte-specific cytokines that are central to deleterious cardiometabolic alterations. They exhibit both pro-inflammatory and anti-inflammatory effects, complicating their association with cardiometabolic disturbances. Thus, understanding the cardiometabolic association of adipokines from a molecular and signaling perspective assumes great importance. This review presents a comprehensive outline of the most prominent adipokines exhibiting pro-inflammatory and/or anti-inflammatory functions in cardiometabolic dysfunction. The review also presents an insight into the pathophysiological implications of such adipokines in different cardiometabolic dysfunction conditions, the status of adipokine druggability, and future studies that can be undertaken to address the existing scientific gap. A clear understanding of the functional and mechanistic role of adipokines can potentially improve our understanding of cardiovascular disease pathophysiology and enhance our current therapeutic regimen in the years to come.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AdipokinesCardiovascular DiseasesHumansAnimalsBiomarkersInflammationSignal Transduction

Stichwörter der Autor:innen

adipokineatherosclerosishypertensioninflammationobesity

Substanzen

AdipokinesBiomarkers

Autor:innen und Institutionen

  • Department of Pharmacological and Pharmaceutical Sciences, College of Pharmacy, University of Houston, 4349 Martin Luther King Blvd., Houston, TX 77204, USA.
  • Department of Pharmaceutical Sciences, College of Pharmacy, Texas A & M University, Kingsville, TX 78363, USA.

ORCID-Profile: Krishna M Boini

Förderung

  • NHLBI NIH HHS
  • NIH HHS
  • National Institute of Health
  • American Heart Association

Zitieren

APA

Datta, S., Koka, S., & Boini, K. M. (2025). Understanding the Role of Adipokines in Cardiometabolic Dysfunction: A Review of Current Knowledge. Biomolecules, 15(5), 612. https://doi.org/10.3390/biom15050612

Vancouver

Datta S, Koka S, Boini KM. Understanding the Role of Adipokines in Cardiometabolic Dysfunction: A Review of Current Knowledge. Biomolecules. 2025;15(5):612. doi:10.3390/biom15050612

BibTeX
@article{Datta2025,
  author = {Datta, Sayantap and Koka, Saisudha and Boini, Krishna M},
  title = {Understanding the Role of Adipokines in Cardiometabolic Dysfunction: A Review of Current Knowledge},
  journal = {Biomolecules},
  year = {2025},
  volume = {15},
  number = {5},
  pages = {612},
  doi = {10.3390/biom15050612}
}
Kostenlos starten →